NCT06212570Not yet recruiting
KeyScope Study in Uganda
KeyScope: First-In-Human Clinical Study for Cancer Diagnosis in Uganda
Source: ClinicalTrials.gov · Last updated 6 Aug 2026
Brief summary (registry, in English)
KeyScope and KeyLoop (collectively called KeySuite) are laparoscopic prototypes that the investigators have designed for the resources, needs and challenges of low- and middle- income countries (LMICs). KeyScope is a laparoscope that plugs into a laptop computer to display images during surgery. It links to a telementoring application so that experienced surgeons can mentor surgeons in capacity-building partnerships. KeyLoop is a laparoscopic retractor that lifts the abdominal wall during surgery, obviating the need for a constant power supply and medical-grade carbon dioxide. The investigators will perform a clinical First-in-Human study at the Uganda Cancer Institute. Ugandan surgeons will use the KeySuite devices to perform biopsies of intra-abdominal tumors.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- First submitted
- 27 Nov 2023
- Start date
- 1 Sept 2026
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Duke University
- Diseases
- Childhood cancers
- NCT number
- NCT06212570
What you commit to
- Study type: Interventional
- Planned participants: 12
- From 1 Sept 2026 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previous major abdominal surgery
Other
- significant comorbidities
- current pregnancy
Who the study is looking for
- diagnosis of intra-abdominal mass suspicious for cancer
- body mass index (BMI) of 18-30
- weight 20-100kg
- biopsy necessary to determine cancer diagnosis and classify pathology
- surgeon determine that laproscopic biopsy it technically appropriate
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Uganda Cancer Institute Coordinator of this site? Confirm its status | Kampala | Uganda | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.